GlassScriptPhysician profile
Mary T Moss
NPI 1720033855
$1,666.10
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $343 · 2021: $713.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $460.41 | 2019-2021 | |
| Daiichi Sankyo INC. | $162.69 | 2019-2021 | |
| Hologic Sales and Service, LLC | $154.13 | 2020-2021 | |
| Therapeuticsmd, INC. | $141.99 | 2019-2021 | |
| Aspira Women'S Health INC | $119.39 | 2021 | |
| Amgen INC. | $98.64 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $84.73 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.44 | 2019-2020 | |
| Coopersurgical, INC. | $40.61 | 2019-2021 | |
| Lupin INC. | $35.84 | 2019-2020 | |
| Pfizer INC. | $32.01 | 2019-2020 | |
| Exeltis, USA INC. | $30.48 | 2019-2020 | |
| Avanos Medical | $29.15 | 2019 | |
| Evofem Biosciences, INC. | $27.72 | 2021 | |
| Duchesnay USA Incorporated | $26.81 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $26.60 | 2019 | |
| Mylan Pharmaceuticals INC. | $25.26 | 2019-2020 | |
| Allergan, INC. | $21.65 | 2019 | |
| Avion Pharmaceuticals | $20.85 | 2019 | |
| Acell, INC. | $20.13 | 2019 | |
| Medtronic, INC. | $19.01 | 2021 | |
| Radius Health, INC. | $15.15 | 2020 | |
| Olympus America INC. | $14.41 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.